Complete Genomics Unveils Cutting-Edge Manufacturing Facility in San Jose

Complete Genomics, a prominent company specializing in genomic sequencing, has recently opened a state-of-the-art manufacturing facility at its headquarters in San Jose, California. This new facility, spanning 10,115 square feet, is set to revolutionize the company's U.S. supply chain, leading to faster delivery times for researchers utilizing cutting-edge next-generation sequencing products for developing diagnostics and therapies for conditions like cancer, Alzheimer's, and obesity.

The facility serves as a central hub for consolidating supply chain resources from California, the U.S., and around the world, ensuring efficient and dependable local supply for American customers. It accommodates research and development, engineering, and ISO manufacturing operations, with plans to introduce the first DNBSEQ-G99 instrument in the second quarter of this year and deliver multiple sequencers by 2024.

Dr. Radoje Drmanac, Co-Founder and Chief Scientific Officer, stressed the significance of a local supply chain, particularly in light of the global disruptions witnessed during the Covid-19 pandemic. The new facility is designed to offer enhanced support and customer experience by reducing lead times.

Established in 2005, Complete Genomics has been at the forefront of developing cost-effective sequencing technology. The company's products are renowned for their high throughput and affordability, earning accolades such as the 2023 R&D 100 Awards and the 2023 BioTech Breakthrough Awards.

For further details on Complete Genomics and its DNA sequencing solutions, please visit their website at www.completegenomics.com.

The inauguration of Complete Genomics' new manufacturing facility marks a significant milestone in advancing genomic sequencing capabilities. With a focus on streamlining the supply chain and enhancing customer experience, the company is poised to continue its legacy of innovation in the field of DNA sequencing, ultimately contributing to the development of groundbreaking diagnostics and therapies for various medical conditions.